BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32946449)

  • 1. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
    Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
    PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
    Gomm W; von Holt K; Thomé F; Broich K; Maier W; Fink A; Doblhammer G; Haenisch B
    JAMA Neurol; 2016 Apr; 73(4):410-6. PubMed ID: 26882076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study.
    Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K
    Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Campylobacter and Salmonella infections following first prescription for PPI: a cohort study using routine data.
    Brophy S; Jones KH; Rahman MA; Zhou SM; John A; Atkinson MD; Francis N; Lyons RA; Dunstan F
    Am J Gastroenterol; 2013 Jul; 108(7):1094-100. PubMed ID: 23588238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.
    Nguyen LH; Lochhead P; Joshi AD; Cao Y; Ma W; Khalili H; Rimm EB; Rexrode KM; Chan AT
    Gastroenterology; 2018 Apr; 154(5):1290-1297.e1. PubMed ID: 29269313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emulating a target trial of proton pump inhibitors and dementia risk using claims data.
    Ahn N; Nolde M; Günter A; Güntner F; Gerlach R; Tauscher M; Amann U; Linseisen J; Meisinger C; Rückert-Eheberg IM; Baumeister SE
    Eur J Neurol; 2022 May; 29(5):1335-1343. PubMed ID: 35170158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of dementia in elderly patients with the use of proton pump inhibitors.
    Haenisch B; von Holt K; Wiese B; Prokein J; Lange C; Ernst A; Brettschneider C; König HH; Werle J; Weyerer S; Luppa M; Riedel-Heller SG; Fuchs A; Pentzek M; Weeg D; Bickel H; Broich K; Jessen F; Maier W; Scherer M
    Eur Arch Psychiatry Clin Neurosci; 2015 Aug; 265(5):419-28. PubMed ID: 25341874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
    Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
    Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.
    Gray SL; Walker RL; Dublin S; Yu O; Aiello Bowles EJ; Anderson ML; Crane PK; Larson EB
    J Am Geriatr Soc; 2018 Feb; 66(2):247-253. PubMed ID: 29134629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
    Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
    PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
    Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
    PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users.
    Abraham NS; Hartman C; Castillo D; Richardson P; Smalley W
    Am J Gastroenterol; 2008 Feb; 103(2):323-32. PubMed ID: 18289200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
    Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia.
    Goldstein FC; Steenland K; Zhao L; Wharton W; Levey AI; Hajjar I
    J Am Geriatr Soc; 2017 Sep; 65(9):1969-1974. PubMed ID: 28590010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
    Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
    J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK.
    Schnier C; McCarthy A; Morales DR; Akbari A; Sofat R; Dale C; Takhar R; Mamas MA; Khunti K; Zaccardi F; Sudlow CL; Wilkinson T;
    Lancet Healthy Longev; 2023 Aug; 4(8):e421-e430. PubMed ID: 37543047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study.
    Douwes RM; Gomes-Neto AW; Eisenga MF; Van Loon E; Schutten JC; Gans ROB; Naesens M; van den Berg E; Sprangers B; Berger SP; Navis G; Blokzijl H; Meijers B; Bakker SJL; Kuypers D
    PLoS Med; 2020 Jun; 17(6):e1003140. PubMed ID: 32542023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.